AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer's disease

/PRNewswire/ -- AstronauTx Ltd. ("AstronauTx"), a biotech company developing novel treatments for Alzheimer's disease and other neurodegenerative disorders,...

Related Keywords

London ,City Of ,United Kingdom ,Denmark ,Boston ,Massachusetts ,United States ,Danish ,British ,Ruth Mckernan ,Astronautx Bio ,Bill Gates ,Eli Lilly ,Otsuka Astex ,Laurence Barker ,Marianne Uteng ,United Kingdom Future Fund ,Life Sciences ,Sv Health Investors ,Johnson ,Dementia Discovery Fund ,Pfizer ,Unitedhealth Group ,Astronautx Ltd ,Dementia Fund ,Players Association ,Novartis Venture Fund ,Quest Diagnostics ,Technology Fund ,Prnewswire Astronautx Ltd ,Bristol Myers Squibb ,Alzheimer Research United Kingdom ,Brandon Capital ,Dementia Discovery ,Innovate United Kingdom ,Managing Director ,Novartis Venture ,Venture Fund ,British Patient Capital ,Research United Kingdom ,Astronautx ,